Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation

• Main Authors: Chuanrui Ma (Author), Xinyu Wang (Author), Jing Zhang (Author), Yun Zhao (Author), Yunqing Hua (Author), Chao Zhang (Author), Guobin Zheng (Author), Guangyan Yang (Author), Jianli Guan (Author), Huahuan Li (Author), Meng Li (Author), Lin Kang (Author), Jiaqing Xiang (Author), Guanwei Fan (Author), Shu Yang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Nonalcoholic fatty liver disease (NAFLD) is defined as liver disease in which more than 5% of hepatocytes are steatotic with little or no alcohol consumption. NAFLD includes benign nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Importantly, NASH is an advanced progression o...